Heteroarylaminopyrazolderivativer nyttige for behandling av diabetes

Den foreliggende oppfinnelse vedrører heteroarylaminopyrazolforbindelser, farmasøytiske sammensetninger og fremgangsmåter for å behandle diabetes og relaterte forstyrrelser. The present invention relates to heteroarylaminopyrazole compounds, pharmaceutical compositions, and methods for treating diab...

Full description

Saved in:
Bibliographic Details
Main Authors MAGNUSON STEVEN R, WICKENS PHILIP L, RUDOLPH JOACHIM, CHUANG CHIH-YUAN, QL NING, OLAGUE ALAN, CHEN LIBING
Format Patent
LanguageNorwegian
Published 22.11.2006
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract Den foreliggende oppfinnelse vedrører heteroarylaminopyrazolforbindelser, farmasøytiske sammensetninger og fremgangsmåter for å behandle diabetes og relaterte forstyrrelser. The present invention relates to heteroarylaminopyrazole compounds, pharmaceutical compositions, and methods for treating diabetes and related disorders.
AbstractList Den foreliggende oppfinnelse vedrører heteroarylaminopyrazolforbindelser, farmasøytiske sammensetninger og fremgangsmåter for å behandle diabetes og relaterte forstyrrelser. The present invention relates to heteroarylaminopyrazole compounds, pharmaceutical compositions, and methods for treating diabetes and related disorders.
Author CHUANG CHIH-YUAN
RUDOLPH JOACHIM
OLAGUE ALAN
CHEN LIBING
MAGNUSON STEVEN R
QL NING
WICKENS PHILIP L
Author_xml – fullname: MAGNUSON STEVEN R
– fullname: WICKENS PHILIP L
– fullname: RUDOLPH JOACHIM
– fullname: CHUANG CHIH-YUAN
– fullname: QL NING
– fullname: OLAGUE ALAN
– fullname: CHEN LIBING
BookMark eNrjYmDJy89L5WRw8UgtSS3KTyyqzEnMzczLL6gsSqzKz0lJLcosSyzJLEstUsirLCnJTE9VSMsvUkhKzUjMS8nJzEtXSCxTSMlMTAJqL-ZhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfF-_kYGBmYmxkamPj7GxKgBAJNCNjM
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID NO20064325LL
GroupedDBID EVB
ID FETCH-epo_espacenet_NO20064325LL3
IEDL.DBID EVB
IngestDate Fri Jul 19 14:57:25 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Norwegian
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_NO20064325LL3
Notes Application Number: NO20060004325
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20061122&DB=EPODOC&CC=NO&NR=20064325L
ParticipantIDs epo_espacenet_NO20064325LL
PublicationCentury 2000
PublicationDate 20061122
PublicationDateYYYYMMDD 2006-11-22
PublicationDate_xml – month: 11
  year: 2006
  text: 20061122
  day: 22
PublicationDecade 2000
PublicationYear 2006
RelatedCompanies BAYER PHARMACEUTICALS CORP
RelatedCompanies_xml – name: BAYER PHARMACEUTICALS CORP
Score 2.6298332
Snippet Den foreliggende oppfinnelse vedrører heteroarylaminopyrazolforbindelser, farmasøytiske sammensetninger og fremgangsmåter for å behandle diabetes og relaterte...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Heteroarylaminopyrazolderivativer nyttige for behandling av diabetes
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20061122&DB=EPODOC&locale=&CC=NO&NR=20064325L
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8Mw8JhT1Dedis4PIkjfii5Nal6KsHZjyNYOmbK3kWTd6EtatqrMX28S1uqLvoUEjssll7vcJ8CdFP6cEUncB0_6LllQ7gpBhSs844TDHHNbS28U-4NX8jyl0wZkVS6MrRP6aYsjao6Smt9L-14XP0asyMZWru9Fpqfyp_4kiJz6d6zVB-xE3aA3TqIkdMIwiBMnfrFrxMN0uAO7Ros2ZfZ7b12TlFL8lij9I9gba2CqPIaGyltwEFaN11qwP9r6u_Vwy3rrE4gGJnAl56uNPsNM5cVmxb9y02Pb9ifTNxKpTVlmyxRpPRSZ9Hs1N7nmiH-gysJ6Crf93iQcuBqdWb31WZzUiA-9M2iqXKXngLDUVBU-40SkRFLGRCd9ZFRKtmALgfEFtP-G0_5v8RIOrZGh03ExvoJmuXpPr7XYLcWNJdg3kyiJxg
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8Mw8JhTnG86FZ1fFaRvRZemXV6KsHajatcOmbK3kWSd9CUdXVXqrzcJ6_RF30ICx-WSy13uE-CGM3dOMMfWnc1dCy8cajHmMIvZygmHKKK6lt4odsMX_Dh1pg3I6lwYXSf0UxdHlBzFJb-X-r1e_hixAh1bubplmZzK74cTLzA3v2OpPiAz6HuDcRIkvun7XpyY8bNewzZyoi3Y7qnivEpzeu2rpJTlb4ky3IedsQQmygNoiLwNLb9uvNaG3dHa3y2Ha9ZbHUIQqsCVnBaVPMNM5MuqoF-56rGt-5PJG2mIqiyzt9SQeqih0u_FXOWaG_TDqC2sR3A9HEz80JLozDZbn8XJBvHIPoamyEV6AgbikqrMJRSzFHOHENZNe8ThnCzIgiF0Cp2_4XT-W7yCVjgZRbPoIX46gz1tcOh2LYTOoVkW7-mFFMElu9TE-wYtmYyz
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Heteroarylaminopyrazolderivativer+nyttige+for+behandling+av+diabetes&rft.inventor=MAGNUSON+STEVEN+R&rft.inventor=WICKENS+PHILIP+L&rft.inventor=RUDOLPH+JOACHIM&rft.inventor=CHUANG+CHIH-YUAN&rft.inventor=QL+NING&rft.inventor=OLAGUE+ALAN&rft.inventor=CHEN+LIBING&rft.date=2006-11-22&rft.externalDBID=L&rft.externalDocID=NO20064325LL